Manufacturers Life Insurance Company, The Tango Therapeutics, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 19,296 shares of TNGX stock, worth $28,751. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,296
Previous 19,227
0.36%
Holding current value
$28,751
Previous $148,000
60.14%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding TNGX
# of Institutions
135Shares Held
91MCall Options Held
1.4KPut Options Held
4.4K-
Trv Gp Iv, LLC Boston, MA16.9MShares$25.1 Million64.97% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA10.7MShares$16 Million5.42% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA10.6MShares$15.8 Million1.53% of portfolio
-
Nextech Invest Ag5.53MShares$8.25 Million3.19% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4MShares$5.96 Million0.07% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $131M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...